Immediate Impact
24 from Science/Nature 70 standout
Citing Papers
Fluorescent Probes for Disease Diagnosis
2024 Standout
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations
2023 Standout
Works of X. Wang being referenced
Phase II clinical trial of neoadjuvant anti-PD-1 (toripalimab) combined with axitinib in resectable mucosal melanoma
2023
MiR-124 regulates early neurogenesis in the optic vesicle and forebrain, targeting NeuroD1
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| X. Wang | 51 | 70 | 91 | 140 | 124 | 26 | 410 | |
| Kai Fruth | 58 | 30 | 91 | 115 | 114 | 34 | 434 | |
| Tamara T. Haque | 21 | 44 | 98 | 93 | 64 | 23 | 403 | |
| Shuguang Han | 61 | 69 | 174 | 25 | 30 | 24 | 393 | |
| Ruchi Kapoor | 33 | 47 | 132 | 33 | 54 | 26 | 429 | |
| Takeshi Kiyoi | 33 | 22 | 163 | 40 | 36 | 38 | 349 | |
| Ryo Utsunomiya | 107 | 10 | 71 | 59 | 44 | 23 | 432 | |
| Constance Hobusch | 31 | 23 | 112 | 120 | 14 | 20 | 443 | |
| B.L. Thomas | 35 | 57 | 185 | 30 | 33 | 17 | 356 | |
| Jing Wu | 91 | 70 | 165 | 61 | 32 | 20 | 393 | |
| T Fülöp | 20 | 143 | 103 | 49 | 67 | 19 | 449 |
All Works
Login with ORCID to disown or claim papers
Loading papers...